Best of 2022

The HER Foundation has accomplished a lot in 2022! We are thankful for the support of our donors and community and want to share the highlights that made this HER’s best year yet! This is what 22 years of Helping Generations survive Hyperemesis Gravidarum (HG) looks like.

Tala Shares #HERstory

The HER Foundation educated me on the website and social media, and I used the HG Care app. When I was scared to take Zofran, they sent me the lastest research. HER understands, and I didn’t feel alone. One day, they will find a cure.

HER Genetic Research Presented at ASHG

What is the cause of hyperemesis gravidarum? Dr. Fejzo presented our team’s results from the largest ever genetic study of HG (7,197 HG cases and 178,953 controls) at the American Society of Human Genetics annual conference in Los Angeles on October 26, 2022.

Dr. Fejzo is interviewed in Inverse

Dr. Marlena Fejzo, geneticist and HER’s Research Advisor and member of the Board of Directors, was featured in the Inverse article, “When morning sickness kills: doctors have dismissed hyperemesis gravidarum for decades, but new research could undo this harmful legacy.”

HER Psychosocial Research

The HER Foundation’s breakthrough psychosocial study shows that Hyperemesis Gravidarum (HG) is not self limiting and has societal implications.

Best of 2021

We put together this list of highlights from 2021! These are some of the people, the work, and the campaigns that made this HER’s best year yet! We are making Hyperemesis Gravidarum (HG) progress!

HER Board Members Lead Study at USC

HER Board members, Marlena Fejzo, PhD, and Patrick Mullen, MD, are running the first study of GDF15 in HG patients in the United States.

Marlena Fejzo, PhD, presents on HER’s genetic research at ASHG Annual Meeting 2021

Marlena Fejzo, PhD, HER Board Member and Research Advisor, presents at the American Society of Human Genetics Annual Meeting on the genetics of Hyperemesis Gravidarum (HG).

Research Summary: Safety of Ondansetron (Zofran) in Pregnancy

Read the latest research on the safety of ondansetron (Zofran) in an HG pregnancy.

How to Support an Employee with HG or other High Risk Complications of Pregnancy

Dozens of mothers bravely raised their voices about the obstacles that prohibited them from being healthy, productive employees during their pregnancies, including insufficient job security and a lack of compassion from employers. We compiled their responses to make a succinct list employers can refer to when attempting to support employees with HG or other high risk pregnancy complications.